ASP Isotopes (NASDAQ:ASPI) COO Sells $47,475.00 in Stock

Key Points

• ASP Isotopes COO Robert Ainscow sold 22,500 shares at an average price of $2.11, generating $47,475. The sale covered tax-withholding obligations tied to vested equity awards and reduced his ownership by 1% to 2.23 million shares.
• ASP Isotopes shares opened at $2.14 and remain near their 12-month low of $2.03, well below the 12-month high of $11.28. The company recently reported a quarterly loss of $0.28 per share, missing analyst expectations.
• Analyst sentiment is mixed, with a consensus rating of Hold and a $13.00 price target; institutional investors own 16.8% of the company.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) COO Robert Ainscow sold 22,500 shares of the firm's stock in a transaction dated Wednesday, October 14th. The shares were sold at an average price of $2.11, for a total value of $47,475.00. Following the sale, the chief operating officer owned 2,225,941 shares in the company, valued at $4,696,735.51. This trade represents a 1.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Robert Ainscow also recently made the following trade(s):

• On Tuesday, September 8th, Robert Ainscow sold 8,438 shares of ASP Isotopes stock. The stock was sold at an average price of $4.29, for a total value of $36,199.02.
• On Wednesday, September 2nd, Robert Ainscow sold 25,000 shares of ASP Isotopes stock. The stock was sold at an average price of $3.90, for a total value of $97,500.00.

ASP Isotopes Price Performance

Shares of ASPI opened at $2.14 on Monday. The company has a current ratio of 3.87, a quick ratio of 3.85 and a debt-to-equity ratio of 0.76. ASP Isotopes Inc. has a 12 month low of $2.03 and a 12 month high of $11.28. The stock's 50 day moving average is $3.40 and its two-hundred day moving average is $4.73. The firm has a market cap of $328.08 million, a P/E ratio of -1.62 and a beta of 3.69.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last announced its earnings results on Friday, August 14th. The company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.17) by ($0.11). ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%. The business had revenue of $5.12 million for the quarter, compared to analyst estimates of $4.47 million.

Institutional Investors Weigh In On ASP Isotopes

Several institutional investors and hedge funds have recently added to or reduced their stakes in ASPI. WINTON GROUP Ltd purchased a new stake in shares of ASP Isotopes in the second quarter valued at about $588,000. Integrated Wealth Concepts LLC purchased a new position in ASP Isotopes during the second quarter worth about $176,000. Squarepoint Ops LLC raised its stake in ASP Isotopes by 75.6% during the second quarter. Squarepoint Ops LLC now owns 123,951 shares of the company's stock worth $771,000 after purchasing an additional 53,354 shares during the period. Amundi acquired a new position in ASP Isotopes in the 2nd quarter valued at about $107,000. Finally, AXQ Capital LP acquired a new position in ASP Isotopes in the 2nd quarter valued at about $80,000. Institutional investors and hedge funds own 16.80% of the company's stock.

Analysts Set New Price Targets

ASPI has been the topic of several recent analyst reports. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of ASP Isotopes in a report on Monday, September 21st. Wall Street Zen upgraded shares of ASP Isotopes from a "strong sell" rating to a "sell" rating in a research report on Saturday, August 22nd. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, ASP Isotopes currently has a consensus rating of "Hold" and a consensus price target of $13.00.

ASP Isotopes Company Profile

ASP Isotopes Inc NASDAQ: ASPI is a development-stage advanced materials company focused on isotope enrichment. The company is developing proprietary technology intended to separate and enrich isotopes for use in several high-value markets, including nuclear energy, medicine, semiconductors, quantum computing and other industrial applications.

ASP Isotopes has described its platform as being designed to provide more efficient and scalable isotope production than certain conventional enrichment methods.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.